137 related articles for article (PubMed ID: 19732447)
1. Safety of topical thrombins: the ongoing debate.
Lomax C
Patient Saf Surg; 2009 Sep; 3(1):21. PubMed ID: 19732447
[TBL] [Abstract][Full Text] [Related]
2. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
3. Topical thrombins: benefits and risks.
Lomax C; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
[TBL] [Abstract][Full Text] [Related]
4. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
Clark JA; Humphries JE; Crean S; Reynolds MW
Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in topical thrombins.
Kessler CM; Ortel TL
Thromb Haemost; 2009 Jul; 102(1):15-24. PubMed ID: 19572062
[TBL] [Abstract][Full Text] [Related]
6. The clinical use and immunologic impact of thrombin in surgery.
Lawson JH
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():98-110. PubMed ID: 16673271
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of topical thrombin as a surgical hemostat.
Lew WK; Weaver FA
Biologics; 2008 Dec; 2(4):593-9. PubMed ID: 19707440
[TBL] [Abstract][Full Text] [Related]
8. Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
Voils SA
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):18S-22S. PubMed ID: 19558281
[TBL] [Abstract][Full Text] [Related]
9. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
10. Topical use of recombinant human thrombin for operative hemostasis.
Anderson CD; Bowman LJ; Chapman WC
Expert Opin Biol Ther; 2009 Jan; 9(1):133-7. PubMed ID: 19063699
[TBL] [Abstract][Full Text] [Related]
11. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
[TBL] [Abstract][Full Text] [Related]
12. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.
Bian J; Chen B; Hershman DL; Marks N; Norris L; Schulz R; Bennett CL
J Clin Oncol; 2017 Jun; 35(17):1945-1951. PubMed ID: 28441110
[TBL] [Abstract][Full Text] [Related]
13. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma.
Nelson PA; Powers JN; Estridge TD; Elder EA; Alea AD; Sidhu PK; Sehl LC; DeLustro FA
J Biomed Mater Res; 2001; 58(6):710-9. PubMed ID: 11745525
[TBL] [Abstract][Full Text] [Related]
14. Thrombin use in surgery: an evidence-based review of its clinical use.
Ham SW; Lew WK; Weaver FA
J Blood Med; 2010; 1():135-42. PubMed ID: 22282693
[TBL] [Abstract][Full Text] [Related]
15. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
16. Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.
Halloran K; Barash PG
Curr Opin Anaesthesiol; 2010 Jun; 23(3):423-7. PubMed ID: 20446348
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibodies to the topical hemostat bovine thrombin.
Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.
Schick A; Miller KL; Lanthier M; Dal Pan G; Nardinelli C
Drug Saf; 2017 Jun; 40(6):497-503. PubMed ID: 28342075
[TBL] [Abstract][Full Text] [Related]
19. Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.
Bishop PD; Lewis KB; Schultz J; Walker KM
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():86-97. PubMed ID: 16673270
[TBL] [Abstract][Full Text] [Related]
20. Whole blood thrombin: development of a process for intra-operative production of human thrombin.
Kumar V; Chapman JR
J Extra Corpor Technol; 2007 Mar; 39(1):18-23. PubMed ID: 17486869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
